COLOgen
Preventive genetic test against sporadic colorectal carcinoma
Genetic polymorphisms analyzed in COLOgen target a pathway involved in cell growth, proliferation, differentiation and apoptosis. COLOgen should be prescribed to individuals with a family history of colorectal cancer or of intestinal polyps.
This test is carried out on a sub-contracted basis by an accredited laboratory.